Did you know?

Past criteria checks 4/6. Vertex Pharmaceuticals has been growing earnings at an average annual rate of 16.2%, while the Biotechs industry saw earnings growing at 17.4% annually. Revenues have been growing at an average rate of 23.4% per year. Vertex Pharmaceuticals's return on equity is 21%, and it has net margins of 35.9%.Vortex Energy Corp. (VRTX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... VRTX Stock Chart & Stats. Advanced Chart > 1d 5d 1m 3m-64.35%. 6m YTD 1y 3y 5y 10y. Day’s Range C$0 - C$0. 52-Week Range C$0.10 - C$2.32. Previous …Nov 30, 2023 · The price-to-earnings ratio for Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) is above average at 26.34x. The 36-month beta value for VRTX is also noteworthy at 0.41. There are mixed opinions on the stock, with 19 analysts rating it as a “buy,” 3 rating it as “overweight,” 9 rating it as “hold,” and 0 rating it as “sell.”. Vertex Pharmaceuticals last posted its quarterly earnings data on November 6th, 2023. The pharmaceutical company reported $4.08 earnings per share for the …VRTX After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...Past criteria checks 4/6. Vertex Pharmaceuticals has been growing earnings at an average annual rate of 16.2%, while the Biotechs industry saw earnings growing at 17.4% annually. Revenues have been growing at an average rate of 23.4% per year. Vertex Pharmaceuticals's return on equity is 21%, and it has net margins of 35.9%.Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Vertex Pharmaceuticals Inc. research and ratings by Barron's. View VRTX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Vertex Pharmaceuticals shares outstanding history from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders ...Vertex shares have soared 400% over the past decade. Vertex Pharmaceuticals ( VRTX -1.03%) has come a long way in the past ten years. In a little over a decade, the company has built a cystic ...Vertex Pharmaceuticals last posted its quarterly earnings data on November 6th, 2023. The pharmaceutical company reported $4.08 earnings per share for the quarter, beating analysts' consensus estimates of $3.53 by $0.55. The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.50 billion.Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $374, moving +0.81% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 1.06%.2. Trading Idea: Buy Vertex Pharmaceuticals (VRTX) Stock Vertex Pharmaceuticals (VRTX) has experienced a decline of around 5.84% in its share price over the past month. However, based on the provided facts, it appears that Vertex Pharmaceuticals is in a strong financial position and could be a good investment opportunity.The latest price target for . Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Stifel on Wednesday, November 22, 2023.The analyst firm set a price target for 373.00 …Stock market news today: S&P 500 hits new 2023 closing high as stocks rise for fifth straight week ... VRTX. Vertex Pharmaceuticals Incorporated. $351.16. 1.03%. add_circle_outline. VRT. Vertiv ...Nov 29, 2023 · A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get Vertex Pharmaceuticals Incorporated (VRTX) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Vertex Pharmaceuticals Incorporated (VRTX) Latest Stock News & Headlines - Yahoo Finance U.S. markets close in 6 hours 17 minutes -7.55(-0.17%) -4.84(-0.01%) -24.98( …BOSTON -- (BUSINESS WIRE)--May 1, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2023 and reiterated full year 2023 financial guidance. “Vertex delivered a strong start to 2023, with outstanding execution across our business.For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. Market Cap: capitalization or market value of a …VRTX US92532F1003 Market Closed - Nasdaq. Other stock markets. 04:00:00 2023-12-01 pm EST 5-day change 1st Jan Change ... Stock Vertex Pharmaceuticals Incorporated - Nasdaq . Consensus Vertex Pharmaceuticals Incorporated. CATEGORIES. Indexes; Equities; Currencies; Commodities ...VRTX stock trades near $180 currently and it is, in faMay 3, 2023 · 7. A cash stockpile of $11.5 billion. Last, b Stock #1: Vertex Pharmaceuticals Incorporated . VRTX is a biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO and SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO. The company’s pipeline includes VX-522, VX-548, Exa-cel, and VX-147, VX-880, VX-970, …VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The stock price of Vertex Pharmaceuticals (NASDAQ: 48.34%. Created with Highstock 2.1.8. Vertex Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest VRTX financial statements, income statements and financial ratios.The stock price for . Vertex Pharmaceuticals (NASDAQ: VRTX) is $354.81 last updated Today at November 30, 2023 at 9:20 PM UTC. Q Does Vertex Pharmaceuticals (VRTX) pay a dividend? Abrahams has a sector perform rating on VRTX

Nov 7, 2023 · Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported upbeat earnings for its third quarter, while sales missed estimates.. Vertex Pharmaceuticals posted adjusted earnings of $4.08 per share ... Vertex currently has an average brokerage recommendation (ABR) of 1.59, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Vortex Energy Corp. (VRTX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... VRTX Stock Chart & Stats. Advanced Chart > 1d 5d 1m 3m-64.35%. 6m YTD 1y 3y 5y 10y. Day’s Range C$0 - C$0. 52-Week Range C$0.10 - C$2.32. Previous …

Vertex Pharmaceuticals. Market Cap. $91B. Today's Change. (-1.23%) -$4.38. Current Price. $350.44. Price as of December 1, 2023, 3:23 p.m. ET. You’re reading a free article with opinions that ...Nov 30, 2023 · View Vertex Pharmaceuticals Incorporated VRTX investment & stock information. Get the latest Vertex Pharmaceuticals Incorporated VRTX detailed stock quotes, stock data, Real-Time ECN, charts ... Find the latest analyst research for Vertex Pharmaceuticals Incorporated Common Stock (VRTX) at Nasdaq.com.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Insider Sell Alert: EVP and CMO Carmen Bozic Sells 5,650 S. Possible cause: At Yahoo Finance, you get free stock quotes, up-to-date news, portfoli.